These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 19016728

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A.
    Sørensen B, Persson E, Ingerslev J.
    Br J Haematol; 2007 Apr; 137(2):158-65. PubMed ID: 17391496
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
    Sørensen B, Ingerslev J.
    Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
    Aljamali MN, Kjalke M, Hedner U, Ezban M, Tranholm M.
    Haemophilia; 2009 Nov; 15(6):1318-26. PubMed ID: 19659796
    [Abstract] [Full Text] [Related]

  • 10. rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats.
    Lauritzen B, Tranholm M, Ezban M.
    J Thromb Haemost; 2009 Apr; 7(4):651-7. PubMed ID: 19175492
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
    Sørensen B, Ingerslev J.
    J Thromb Haemost; 2004 Jan; 2(1):102-10. PubMed ID: 14717973
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.
    Campbell RA, Fischer TH, Wolberg AS.
    Br J Haematol; 2007 Jul; 138(1):82-93. PubMed ID: 17555451
    [Abstract] [Full Text] [Related]

  • 16. Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms.
    Ogiwara K, Nogami K, Shima M.
    Thromb Haemost; 2011 Oct; 106(4):665-74. PubMed ID: 21901232
    [Abstract] [Full Text] [Related]

  • 17. Factor VIIa analog has marked effects on platelet function and clot kinetics in blood from patients with hemophilia A.
    Brophy DF, Martin EJ, Nolte ME, Kuhn JG, Barrett JC, Ezban M.
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):539-46. PubMed ID: 20581663
    [Abstract] [Full Text] [Related]

  • 18. Neonatal thrombocytopenia: Thrombin generation in presence of reduced platelet counts and effects of rFVIIa in cord blood.
    Haidl H, Pohl S, Leschnik B, Gallistl S, Muntean W, Schlagenhauf A.
    Sci Rep; 2019 May 29; 9(1):8014. PubMed ID: 31142810
    [Abstract] [Full Text] [Related]

  • 19. Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia-like conditions in vitro.
    Kjalke M, Johannessen M, Hedner U.
    Semin Hematol; 2001 Oct 29; 38(4 Suppl 12):15-20. PubMed ID: 11735105
    [Abstract] [Full Text] [Related]

  • 20. Experiences with recombinant human factor VIIa in patients with thrombocytopenia.
    Goodnough LT.
    Semin Hematol; 2004 Jan 29; 41(1 Suppl 1):25-9. PubMed ID: 14872417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.